USD 0.0
(400.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 35.64 Thousand USD | -9.6% |
2015 | 39.43 Thousand USD | -10.39% |
2014 | 44 Thousand USD | 0.0% |
2013 | 44 Thousand USD | 0.0% |
2012 | 44 Thousand USD | 0.0% |
2011 | 44 Thousand USD | 0.0% |
2010 | 44 Thousand USD | 0.0% |
2009 | 44 Thousand USD | 0.0% |
2008 | 44 Thousand USD | -11.53% |
2007 | 49.73 Thousand USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | -100.0% |
1999 | 460 Thousand USD | 1050.0% |
1998 | 40 Thousand USD | -81.82% |
1997 | 220 Thousand USD | 10.0% |
1996 | 200 Thousand USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q3 | 35.11 Thousand USD | -1.59% |
2017 Q1 | 34.44 Thousand USD | -3.37% |
2017 FY | - USD | -100.0% |
2017 Q4 | - USD | -100.0% |
2017 Q2 | 35.68 Thousand USD | 3.6% |
2016 FY | 35.64 Thousand USD | -9.6% |
2016 Q3 | 37.59 Thousand USD | -2.14% |
2016 Q2 | 38.41 Thousand USD | -1.04% |
2016 Q4 | 35.64 Thousand USD | -5.18% |
2016 Q1 | 38.81 Thousand USD | -1.55% |
2015 FY | 39.43 Thousand USD | -10.39% |
2015 Q4 | 39.43 Thousand USD | -3.27% |
2015 Q1 | 41.19 Thousand USD | -6.37% |
2015 Q2 | 40.8 Thousand USD | -0.95% |
2015 Q3 | 40.76 Thousand USD | -0.09% |
2014 Q3 | 44 Thousand USD | 0.0% |
2014 Q2 | 44 Thousand USD | 0.0% |
2014 FY | 44 Thousand USD | 0.0% |
2014 Q4 | 44 Thousand USD | 0.0% |
2014 Q1 | 44 Thousand USD | 0.0% |
2013 FY | 44 Thousand USD | 0.0% |
2013 Q1 | 44 Thousand USD | 0.0% |
2013 Q2 | 44 Thousand USD | 0.0% |
2013 Q3 | 44 Thousand USD | 0.0% |
2013 Q4 | 44 Thousand USD | 0.0% |
2012 Q1 | 44 Thousand USD | 0.0% |
2012 Q3 | 44 Thousand USD | 0.0% |
2012 Q4 | 44 Thousand USD | 0.0% |
2012 FY | 44 Thousand USD | 0.0% |
2012 Q2 | 44 Thousand USD | 0.0% |
2011 FY | 44 Thousand USD | 0.0% |
2011 Q4 | 44 Thousand USD | 0.0% |
2011 Q3 | 44 Thousand USD | 0.0% |
2011 Q2 | 44 Thousand USD | 0.0% |
2011 Q1 | 44 Thousand USD | 0.0% |
2010 Q2 | 44 Thousand USD | 0.0% |
2010 Q4 | 44 Thousand USD | 0.0% |
2010 FY | 44 Thousand USD | 0.0% |
2010 Q3 | 44 Thousand USD | 0.0% |
2010 Q1 | 44 Thousand USD | 0.0% |
2009 Q3 | 44 Thousand USD | 0.0% |
2009 Q1 | 44 Thousand USD | 0.0% |
2009 FY | 44 Thousand USD | 0.0% |
2009 Q4 | 44 Thousand USD | 0.0% |
2009 Q2 | 44 Thousand USD | 0.0% |
2008 Q4 | 44 Thousand USD | 0.0% |
2008 Q1 | 46.89 Thousand USD | -5.71% |
2008 Q2 | 44 Thousand USD | -6.17% |
2008 Q3 | 44 Thousand USD | 0.0% |
2008 FY | 44 Thousand USD | -11.53% |
2007 Q3 | 52.52 Thousand USD | 19.37% |
2007 Q4 | 49.73 Thousand USD | -5.31% |
2007 Q2 | 44 Thousand USD | 0.0% |
2007 FY | 49.73 Thousand USD | 0.0% |
2007 Q1 | 44 Thousand USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2000 Q2 | - USD | -100.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | 450 Thousand USD | -2.17% |
2000 FY | - USD | -100.0% |
1999 Q2 | 10 Thousand USD | -50.0% |
1999 Q1 | 20 Thousand USD | -50.0% |
1999 Q3 | 10 Thousand USD | 0.0% |
1999 Q4 | 460 Thousand USD | 4500.0% |
1999 FY | 460 Thousand USD | 1050.0% |
1998 FY | 40 Thousand USD | -81.82% |
1998 Q3 | 70 Thousand USD | -41.67% |
1998 Q2 | 120 Thousand USD | -29.41% |
1998 Q4 | 40 Thousand USD | -42.86% |
1998 Q1 | 170 Thousand USD | -22.73% |
1997 Q3 | 200 Thousand USD | -9.09% |
1997 Q4 | 220 Thousand USD | 10.0% |
1997 Q2 | 220 Thousand USD | 29.41% |
1997 Q1 | 170 Thousand USD | -15.0% |
1997 FY | 220 Thousand USD | 10.0% |
1996 Q3 | 130 Thousand USD | -18.75% |
1996 Q1 | 160 Thousand USD | 0.0% |
1996 FY | 200 Thousand USD | 0.0% |
1996 Q2 | 160 Thousand USD | 0.0% |
1996 Q4 | 200 Thousand USD | 53.85% |
1995 Q4 | - USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q3 | - USD | -100.0% |
1994 Q2 | 150 Thousand USD | 0.0% |
1994 Q4 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | NaN% |
Ansell Limited | 705.27 Million USD | 100.0% |
Ansell Limited | 706.6 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 22.41 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | - USD | NaN% |
Psykey, Inc. | 625 Thousand USD | 100.0% |
ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
Encision Inc. | 67.33 Thousand USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 382.83 Thousand USD | 100.0% |
LifePoint, Inc. | 151.73 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | 100.0% |
Remedent, Inc. | - USD | NaN% |
Reflect Scientific, Inc. | 179.96 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 849.37 Million USD | 100.0% |
Sector 10, Inc. | - USD | NaN% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 100.0% |
SheerVision, Inc. | - USD | NaN% |
United Health Products, Inc. | 48.48 Thousand USD | 100.0% |
Vasamed, Inc. | 18.95 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | 100.0% |
Yubo International Biotech Limited | 390.44 Thousand USD | 100.0% |